Pharmacology
Conference Coverage
Esketamine bests quetiapine for severe depression in head-to-head trial
“These patients are not resistant, they just have resistance to monoaminergic drugs.”
News
Proton pump inhibitors linked to increased dementia risk
“The association between PPI use and dementia was unambiguously largest among the youngest cases of dementia.”
Conference Coverage
Tirzepatide with insulin glargine improves type 2 diabetes
“Demonstrating superiority over insulin lispro in terms of the so-called trio of A1c, weight loss, and hypoglycemic events, tirzepatide offers...
News
FDA approves first tocilizumab biosimilar
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
Original Research
Impact of Liraglutide to Semaglutide Conversion on Glycemic Control and Cost Savings at a Veterans Affairs Medical Center
Semaglutide and liraglutide are glucagon-like peptide 1 receptor agonists (GLP-1 RAs) that are approved by the US Food...
News
FDA gives semaglutide two drug safety–related label changes
The second addition concerns a new adverse reaction that was identified during the postmarketing experience: gastrointestinal ileus, an intestinal...
News
Study: Antiviral med linked to COVID mutations that can spread
“There aren’t any widely circulating variants that have the signature. At the moment there’s nothing that’s transmitted very widely that’s due to...
News
Paxlovid weaker against current COVID-19 variants
But when looking at death alone, the antiviral was still highly effective.
Conference Coverage
Tirzepatide superior to semaglutide for A1c control, weight loss
“Although the efficacy of the high tirzepatide dose might make it a favorable choice, its real-world application can be affected on an individual’...
News
MDMA effective in diverse patients with PTSD
About 86.5% of participants treated with MDMA-AT achieved a clinically meaningful benefit.